Arkolith/Insider Trading/EXOZ/Form 4

Korman Tyler Paz

Chief Scientific OfficerEXOZYMES INC. (EXOZ) · full profile →Form 4 · filed Apr 10, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$15K
Net Open-Market Flow
-$15K
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Apr 9, 2026Sell(S)750$10.53$8K729K
Apr 8, 2026Sell(S)750$10.04$8K730K

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001493152-26-016166) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML